COMMUNIQUÉS West-GlobeNewswire

OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer
01/02/2019
MIAMI, Feb. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s point-of-care Sangia Total Prostate Specific Antigen ( [...]
AroCell launches new website
01/02/2019
Today AroCell is launching its new website. The goal with the new website is to facilitate for our customers, business partner, and investors to find relevant information about AroCell. The website (arocell.com) informs [...]
Auris Medical Announces Full Repayment of Hercules Loan Facility
01/02/2019
Zug, Switzerland, February 1, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Dentsply Sirona to Host Fourth Quarter and Full Year 2018 Conference Call on March 1st
01/02/2019
YORK, Pa., Feb. 01, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Friday, March 1 [...]
AVROBIO, Inc. Announces Time Change for Analyst and Investor Presentation and Webcast, now 5:30 p.m. ET on Wednesday, February 6, 2019
01/02/2019
CAMBRIDGE, Mass., Feb. 01, 2019 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced a time change for its analyst and investor presentation [...]
Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction
01/02/2019
INDIANAPOLIS and STAMFORD, CT, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY) (“Lilly”) and Loxo Oncology, Inc. (NASDAQ: LOXO) (“Loxo Oncology”) today announced the expiration of the waiting period [...]
Abeona Therapeutics présentera de nouvelles données de soutien pour les nouvelles thérapies géniques au WORLDSymposium™
01/02/2019
NEW YORK et CLEVELAND, 01 févr. 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), société biopharmaceutique de stade clinique de premier plan spécialisée dans le développement de nouvelles thérapies [...]
Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres
01/02/2019
MELBOURNE, Australia, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the execution of a 3-way [...]
Immunicum AB (publ) Announces Upcoming Investor Events in February
01/02/2019
Press Release 1 February 2019 Immunicum AB (publ) Announces Upcoming Investor Events in February Immunicum AB (publ; IMMU.ST) announced today that Carlos de Sousa, CEO of Immunicum, and other members of the management [...]
Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
01/02/2019
Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide Sales remained broadly unchanged in Danish kroner and increased [...]
DBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference
01/02/2019
Montrouge, France, February 1, 2019 DBV Technologies to Present at the 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a [...]
DBV Technologies invitée à presenter à la 8th Annual Leerink Partners Global Healthcare Conference
01/02/2019
Montrouge, France, le 1 février (7h30 CET), 2019 DBV Technologies invitée à presenter à la 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN : FR0010417345 - Nasdaq Stock [...]
Biocartis Group NV: Disclosure of a transparency notification
01/02/2019
PRESS RELEASE: REGULATED INFORMATION 1 February 2019, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 1 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States
01/02/2019
SHANGHAI, China, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (“Hua” or “the Company”; Stock Code: 2552.HK) a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the [...]
OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator
01/02/2019
MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced an update on the ongoing development plans of OPK-88004, a selective androgen receptor modulator (SARM). OPK-88004 has the ability [...]
Future Non-Coverage Determination for 4Kscore Test Posted by Novitas
01/02/2019
MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a notice of a future non-coverage determination for the 4Kscore test® to be effective [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/02/2019
CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2019, that were previously [...]
Resverlogix Closes $6.6 Million Private Placement with Shenzhen Hepalink
01/02/2019
CALGARY, Alberta, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 2.2 million equity units to Shenzhen [...]
Nuvectra® Appoints Dr. Fred B. Parks as Chief Executive Officer
31/01/2019
Elects Christopher G. Chavez as a Member of the Board of Directors PLANO, Texas, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the [...]

Pages